Hal Barron, CSO at my former employer pharma giant GSK, takes helm of Longevity company Altos

The CSO of my former employer, GSK, just jumped ship to the new $3 BILLION longevity science company Altos (presumably also funded by Amazon's Jeff Bezos.)

I indirectly saw it coming while I worked at GSK. I elaborate in my blog entry on

A "Seismic Shift" in Longevity Science : Mainstream Acceptance + Large Funding ( https://julianspolymathexplorations.blogspot.com/2022/01/longevity-science-altos-big-pharma-mainstream-funding.html )

Big Pharma is at long last embracing Longevity Science. The corollary: longevity science is entering Mainstream (with capital "M")


Login or Signup to leave a comment
Stefani Robnett4 months ago

I love that pharma is starting to prioritize longevity - great progress

Find your community. Ask questions. Science is better when we troubleshoot together.
Find your community. Ask questions. Science is better when we troubleshoot together.

Have a question?

Contact support@scifind.net or check out our support page.